CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS

Aim. Hospital-based economic analysis for the use of thrombopoietin receptor agonists (TRA) Eltrombopag and Romiplostim has been performed in patients with chronic idiopathic thrombocytopenic purpura (ITP) at the background failure of previous treatment options. Materials and methods. Two models for...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva
Aineistotyyppi: Artigo
Kieli:Russo
Julkaistu: IRBIS LLC 2016-02-01
Sarja:Фармакоэкономика
Aiheet:
idiopathic thrombocytopenic purpura (itp)
cost-minimization analysis
budget impact analysis
thrombopoietin receptor agonist (tpo-ra)
eltrombopag
romiplostim
Linkit:https://www.pharmacoeconomics.ru/jour/article/view/130
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia